Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Reg Anesth Pain Med ; 44(1): 118-121, 2019 01.
Artigo em Inglês | MEDLINE | ID: mdl-30640663

RESUMO

In patients with a history of a hypersensitivity reaction to iodinated contrast medium, iodinated contrast medium is avoided, antihistamine and steroid premedication are given, or a gadolinium-based contrast agent is employed. Six patients with a history of a hypersensitivity reaction to iodinated contrast medium and who were not premedicated had an unintentional injection of iodinated contrast. None of the patients developed a moderate or severe reaction. All patients had gadopentetate dimeglumine in one of their injections; three had repeated injections of the gadopentetate. The lack of a significant reaction may be due to any or all of the following: questionable history of iodinated contrast reaction, low dose of iodinated contrast given, concomitant injection of (epidural) steroid, and slower absorption from epidural compared with intravenous injection. While it is reassuring to know that there is a low possibility of a moderate to severe reaction in these patients, every effort should be made to avoid this scenario, appropriate drugs and resuscitation equipment should be immediately available, and the patients should be observed adequately and followed for the possibility of late reactions. Recent publications have called for caution in the use of gadolinium-based contrast agents.


Assuntos
Meios de Contraste/efeitos adversos , Hipersensibilidade a Drogas/diagnóstico por imagem , Gadolínio DTPA/efeitos adversos , Manejo da Dor/métodos , Idoso , Idoso de 80 Anos ou mais , Hipersensibilidade a Drogas/prevenção & controle , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos
2.
Curr Opin Anaesthesiol ; 30(3): 435-440, 2017 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-28448298

RESUMO

PURPOSE OF REVIEW: The aim of this review is to examine data relating to perioperative management of the patient with neuromuscular disorders RECENT FINDINGS: Patients with pre-existing neuromuscular disorders are at risk for a number of postoperative complications that are related to anesthetic drugs that are administered intraoperatively. Careful preoperative assessment is necessary to reduce morbidity and mortality. In particular, the risk of postoperative respiratory failure and need for long-term ventilation should be reviewed with patients. The use of succinylcholine should be avoided in muscular dystrophies, motor neuron diseases, and intrinsic muscle disease due to a risk of malignant hyperthermia, hyperkalemia, rhabdomyolysis, and cardiac arrest. The use of quantitative neuromuscular monitoring should be strongly considered whenever nondepolarizing neuromuscular blocking agents are administered. A number of case series and reports have been recently published demonstrating that sugammadex can be safely used in patients with neuromuscular disease; the risk of residual neuromuscular is nearly eliminated when this agent is administered intraoperatively. SUMMARY: Careful assessment and management of patients with underlying neuromuscular diseases is required to reduce postoperative complications. This article reviews the anesthetic implications of patients undergoing surgery with neuromuscular disorder.


Assuntos
Anestesia/efeitos adversos , Anestésicos/efeitos adversos , Bloqueadores Neuromusculares/efeitos adversos , Doenças Neuromusculares/complicações , Assistência Perioperatória/métodos , Complicações Pós-Operatórias/etiologia , Procedimentos Cirúrgicos Operatórios/efeitos adversos , Anestesia/métodos , Anestésicos/administração & dosagem , Parada Cardíaca/induzido quimicamente , Parada Cardíaca/prevenção & controle , Humanos , Hiperpotassemia/induzido quimicamente , Complicações Intraoperatórias/induzido quimicamente , Complicações Intraoperatórias/prevenção & controle , Hipertermia Maligna/etiologia , Bloqueadores Neuromusculares/administração & dosagem , Doenças Neuromusculares/epidemiologia , Monitoração Neuromuscular , Complicações Pós-Operatórias/prevenção & controle , Prevalência , Insuficiência Respiratória/prevenção & controle , Rabdomiólise/induzido quimicamente , Rabdomiólise/prevenção & controle , Medição de Risco , Succinilcolina/administração & dosagem , Succinilcolina/efeitos adversos , Sugammadex , gama-Ciclodextrinas/administração & dosagem , gama-Ciclodextrinas/efeitos adversos
3.
J Clin Gastroenterol ; 40(3): 275-8, 2006 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-16633136

RESUMO

Probiotics are live microbial organisms that are administrated as supplements or in foods to benefit the host. It is the recommendation that they may be helpful in the prevention and treatment of acute diarrhea in adults and children, the prevention of antibiotic-associated diarrhea in adults and children, and the maintenance of remission and prevention of pouchitis. Although early results indicate that probiotics may also be useful in immunologic modulation to prevent atopy, treatment of radiation intestinal disease, vaginosis, ulcerative colitis, and the irritable bowel syndrome, the studies available are not sufficient to say they are definitely helpful. Even fewer data are available to recommend probiotics for the treatment of H pylori and Crohn disease and for the prevention of cardiovascular risk factors or other degenerative diseases. Clearly, larger and better-designed studies of probiotics are necessary, including comparative and dose-ranging trials.


Assuntos
Gastroenteropatias/prevenção & controle , Guias de Prática Clínica como Assunto , Probióticos/uso terapêutico , Doenças Cardiovasculares/prevenção & controle , Feminino , Gastroenteropatias/imunologia , Humanos , Masculino , Vaginose Bacteriana/prevenção & controle
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA